Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Revenue | 34M | 69M |
| Research and development | 54M | 60M |
| Selling, general and administrative | 32M | 35M |
| Operating expenses | 86M | 95M |
| Operating income | −52M | −26M |
| Interest expense | — | 2M |
| Net income | −46M | 7M |
| Earnings per share | −3.56 | 1.05 |
| Earnings per share, diluted | −3.56 | 1.04 |
| Weighted average shares | 13M | 7M |
| Weighted average shares, diluted | 13M | 7M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 99M | 111M | 45M | 62M | 77M | 86M | 99M | 124M |
| Short-term investments | 2M | 5M | 0 |
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Operating cash flow | −66M | −58M |
| Depreciation and amortisation | 1M | 3M |
| Share-based compensation | 10M | 13M |
| Capital expenditure | 85,000 | 250,000 |
| Investing cash flow | −634,000 | −215,000 |
| Financing cash flow | 95M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 0 |
| — |
| 413,000 |
| 2M |
| — |
| Receivables | 4M | 0 | 4,000 | 0 | 4,000 | 229,000 | 188,000 | 207,000 |
| Current assets | 109M | 119M | 52M | 70M | 82M | 95M | 111M | 144M |
| Property, plant and equipment | 1M | 1M | 2M | 2M | 3M | 3M | 4M | 4M |
| Total assets | 144M | 154M | 94M | 109M | 124M | 136M | 153M | 166M |
| Current liabilities | 8M | 9M | 15M | 14M | 12M | 15M | 12M | 33M |
| Total liabilities | 68M | 62M | 77M | 75M | 75M | 80M | 88M | 91M |
| Equity | 76M | 92M | 17M | 34M | 49M | 56M | 65M | 75M |
| Shares outstanding | 26M | 24M | 12M | 12M | 11M | 8M | 7M | 7M |
| Shares issued | 26M | 24M | 12M | 12M | 11M | 8M | 8M | 7M |
| 50M |